Healthcare & Life Sciences

Strand Therapeutics

aliveseries-b
series-b
Stage
2018
Founded
2
Investors

About

Strand Therapeutics is a clinical-stage biotechnology company developing programmable mRNA therapies aimed at treating cancer and other serious diseases.

Explore Strand Therapeutics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.